18F-FDG PET complemented with sentinel lymph node biopsy in the detection of axillary involvement in breast cancer

This publication has 10 references indexed in Scilit:

• Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures
  European Journal of Nuclear Medicine and Molecular Imaging, 2001
• Positron emission tomography in breast cancer: a clinicopathological correlation of results.
  The British Journal of Radiology, 1999
• Prospective comparison of 18 F-FDG PET with conventional imaging modalities (CT, MRI, US) in lymph node staging of head and neck cancer
  European Journal of Nuclear Medicine and Molecular Imaging, 1998
• Staging of the Axilla in Breast Cancer
  Annals of Surgery, 1998
• Axillary lymph node metastases: screening with [F-18]2-deoxy-2-fluoro-D-glucose (FDG) PET.
  Radiology, 1997
• Prospective evaluation of fluorine-18 fluorodeoxyclucose positron emission tomography in breast cancer for staging of the axilla related to surgery and immunocytochemistry
  European Journal of Nuclear Medicine and Molecular Imaging, 1996
• Assessment of Axillary Lymph Node Involvement in Breast Cancer Patients With Positron Emission Tomography Using Radiolabeled 2-(Fluorine-18)-fluoro-2-deoxy-D-glucose
  JNCI Journal of the National Cancer Institute, 1996
• Metabolic characterization of breast tumors with positron emission tomography using F-18 fluorodeoxyglucose.
  Journal of Clinical Oncology, 1996
• Micrometastases to axillary lymph nodes from carcinoma of breast: Detection by immunohistochemistry and prognostic significance
  British Journal of Cancer, 1987
• Glucose utilization of cerebral gliomas measured by [ ¹⁸ F] fluorodeoxyglucose and positron emission tomography
  Neurology, 1982